Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 178.20M
March 31, 2026 58.70M
December 31, 2025 152.70M
September 30, 2025 207.40M
June 30, 2025 154.40M
March 31, 2025 109.30M
December 31, 2024 173.30M
September 30, 2024 244.80M
June 30, 2024 281.10M
March 31, 2024 141.60M
December 31, 2023 251.60M
September 30, 2023 230.70M
June 30, 2023 168.20M
March 31, 2023 219.50M
December 31, 2022 205.60M
September 30, 2022 258.30M
June 30, 2022 227.50M
Date Value
March 31, 2022 152.20M
December 31, 2021 301.00M
September 30, 2021 261.90M
June 30, 2021 263.80M
March 31, 2021 126.90M
December 31, 2020 306.00M
September 30, 2020 281.50M
June 30, 2020 89.20M
March 31, 2020 253.10M
December 31, 2019 87.00M
September 30, 2019 197.90M
June 30, 2019 -5.90M
March 31, 2019 75.00M
December 31, 2018
September 30, 2018
June 30, 2018 -23.80M
March 31, 2018 46.20M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 162.01M
Champions Oncology, Inc. -1.998M
Personalis, Inc. -25.77M
Adaptive Biotechnologies Corp. -6.40M
10X Genomics, Inc. 16.97M